| Financial Year |
March 31 2023 |
| Monetary Funds |
84,493,972.73 |
| Held-for-trading Financial Assets |
256,265,471.24 |
| Notes Receivable |
20,116,318.11 |
| Accounts Receivable |
404,352,118.93 |
| Advances to Suppliers |
6,614,302.37 |
| Other Receivables |
8,312,238.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
292,675,207.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,381,727.45 |
| Total Current Assets |
1,172,180,404.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
247,753,128.00 |
| Under-construction Projects |
347,847,620.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
162,884,598.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,481,390.46 |
| Deferred Income Tax Assets |
8,004,783.79 |
| Other Non-Current Assets |
2,777,982.31 |
| Sub-Total of Non-Current Assets |
825,141,518.81 |
| Total Assets |
1,997,321,922.82 |
| Short-Term Loans |
11,241,750.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
156,583,623.10 |
| Accounts Payable |
367,810,413.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,230,127.83 |
| Taxes Payable |
9,170,615.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,753,995.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,416,693.24 |
| Sub-Total of Current Liabilities |
594,978,474.57 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,449,181.16 |
| Total Liabilities |
613,427,655.73 |
| Paid-In Capital(Or Share Stock) |
295,721,200.00 |
| Capital Surplus |
481,440,828.70 |
| Surplus Reserve |
91,052,544.83 |
| LESS:Treasury Stock |
22,269,424.97 |
| Undistributed Profits |
539,619,409.02 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,383,894,267.09 |
| Owner's Equity（Stockholder's Equity） |
1,383,894,267.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,997,321,922.82 |
